6 papers
ClinicalReTrial: Clinical Trial Redesign with Self-Evolving Agents
Sixue Xing, Kerui Wu, Xuanye Xia +3
Clinical trials constitute a critical yet exceptionally challenging and costly stage of drug development ($2.6B per drug), where protocols are encoded as complex natural language…
Graph Diffusion Transformers are In-Context Molecular Designers
Gang Liu, Jie Chen, Yihan Zhu +4
In-context learning allows large models to adapt to new tasks from a few demonstrations, but it has shown limited success in molecular design. Existing databases such as ChEMBL con…
Scientific Algorithm Discovery by Augmenting AlphaEvolve with Deep Research
Gang Liu, Yihan Zhu, Jie Chen +1
Large language models hold promise as scientific assistants, yet existing agents either rely solely on algorithm evolution or on deep research in isolation, both of which face crit…
MolTextNet: A Two-Million Molecule-Text Dataset for Multimodal Molecular Learning
Yihan Zhu, Gang Liu, Eric Inae +1
Small molecules are essential to drug discovery, and graph-language models hold promise for learning molecular properties and functions from text. However, existing molecule-text d…
Multimodal Large Language Models for Inverse Molecular Design with Retrosynthetic Planning
Gang Liu, Michael Sun, Wojciech Matusik +2
While large language models (LLMs) have integrated images, adapting them to graphs remains challenging, limiting their applications in materials and drug design. This difficulty st…
Learning Molecular Representation in a Cell
Gang Liu, Srijit Seal, John Arevalo +4
Predicting drug efficacy and safety in vivo requires information on biological responses (e.g., cell morphology and gene expression) to small molecule perturbations. However, curre…